Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Clinical trial NCT02213705 · COMPLETED
Trial details
- NCT number
- NCT02213705
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-06
- Primary completion
- 2020-02-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.